Published in Pathologica on July 12, 1974
Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest (1983) 3.47
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63
Thrombin infusion in endotoxin-treated rabbits reduces the plasma levels of plasminogen activator inhibitor: evidence for a protein-C-mediated mechanism. Blood (1989) 1.42
Cancer cell procoagulant activity: evaluation by an amidolytic assay. Thromb Res (1980) 1.41
[A longitudinal entomologic survey on the transmission of malaria in Ouagadougou (Burkina Faso)]. Parassitologia (1986) 1.30
Pseudoaneurysm as a complication of ankle arthroscopy. Arthroscopy (2001) 1.17
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol (2007) 1.16
Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology (1983) 1.15
Effect of carbohydrate counting and medical nutritional therapy on glycaemic control in Type 1 diabetic subjects: a pilot study. Diabet Med (2010) 1.15
New features of dislocation images in third-generation synchrotron radiation topographs. J Synchrotron Radiat (1996) 1.12
Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues. Blood (1983) 1.10
Evidence that cells from experimental tumours can activate coagulation factor X. Br J Cancer (1979) 1.07
Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Exp Brain Res (2008) 1.04
Monitoring of the heavy-metal hyperaccumulation in vegetal tissues by X-ray radiography and by femto-second laser induced breakdown spectroscopy. Microsc Res Tech (2007) 1.03
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. J Clin Invest (1998) 0.99
Helicobacter pylori neutrophil-activating protein stimulates tissue factor and plasminogen activator inhibitor-2 production by human blood mononuclear cells. J Infect Dis (2001) 0.98
Reproducibility of fMRI in the clinical setting: implications for trial designs. Neuroimage (2008) 0.98
C-reactive protein and erythrocyte sedimentation rate changes following arthroscopically assisted anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc (2001) 0.97
High resolution MR anatomy of the subthalamic nucleus: imaging at 9.4 T with histological validation. Neuroimage (2011) 0.93
Interaction of platelets with bacterial endotoxins. Agents Actions (1983) 0.92
Cancer procoagulant in human tumor cells: evidence from melanoma patients. Cancer Res (1986) 0.92
Possible mechanisms of fibrin deposition in the hypereosinophilic syndrome. Haemostasis (1989) 0.88
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells. Kidney Int (1999) 0.87
Letter: The fibrinogenolytic pathway of fibrinogen catabolism: a reply. Thromb Res (1974) 0.86
Ewing's sarcoma of the mandible and maxilla. A report of three cases from the Istituto Beretta. Oral Surg Oral Med Oral Pathol (1986) 0.85
Complement-dependent and complement-independent interactions of bacterial lipopolysaccharides and mucopeptides with rabbit and human platelets. Thromb Haemost (1979) 0.85
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Thromb Haemost (1997) 0.84
Detection of fibrinogen antigens with two latex techniques applied to urine concentrates. J Clin Pathol (1973) 0.84
Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential. J Thromb Haemost (2008) 0.83
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression. J Thromb Haemost (2005) 0.83
Retinoids inhibit the respiratory burst and degranulation of stimulated human polymorphonuclear leukocytes. Agents Actions (1991) 0.83
Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function. Eur J Cancer Clin Oncol (1983) 0.83
Induction of monocyte-macrophage procoagulant activity by transformed cell lines. J Immunol (1986) 0.83
Arachidonic acid and leukotriene B4 induce aggregation of human peripheral blood mononuclear leucocytes in vitro. Br J Haematol (1984) 0.83
Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1. Childs Nerv Syst (1993) 0.82
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor. J Thromb Haemost (2010) 0.82
Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency. Biochem Pharmacol (1983) 0.82
Gentisic acid: an aspirin metabolite with multiple effects on human blood polymorphonuclear leukocytes. Biochem Pharmacol (1986) 0.82
Stroke in two young siblings with congenital dysfibrinogenemia. Ital J Neurol Sci (1983) 0.81
The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood. J Thromb Haemost (2011) 0.81
L-carnitine and isovaleryl L-carnitine fumarate positively affect human osteoblast proliferation and differentiation in vitro. Calcif Tissue Int (2005) 0.81
Evidence that washed human platelets possess factor-X activator activity. Br J Haematol (1977) 0.81
Microscopical and ultrastructural investigations on the development of the blood-brain barrier in the chick embryo optic tectum. Acta Neuropathol (1986) 0.81
Cancer cell procoagulants and their pharmacological modulation. Haemostasis (1984) 0.81
Legionella pneumophila and related organisms induce the generation of procoagulant activity by peripheral mononuclear cells in vitro. Infection (1982) 0.80
Cancer cell procoagulant: a novel vitamin K-dependent activity. Thromb Res (1981) 0.80
Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis. Br J Haematol (1999) 0.80
Platelet aggregation and stimulation of leucocyte procoagulant activity by rickettsial lipopolysaccharides in rabbits and in man. Experientia (1981) 0.80
Relationship between café-au-lait spots as the only symptom and peripheral neurofibromatosis (NF1): a follow-up study. Eur J Pediatr (1993) 0.80
Lower limb arterio-venous shunts, autonomic neuropathy and diabetic foot. Diabetes Res Clin Pract (1992) 0.80
Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA. Thromb Haemost (2001) 0.80
[Effects of chronic hypoxia on microcirculation of the central nervous system during embryonic development]. Boll Soc Ital Biol Sper (1984) 0.79
Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy. Horm Metab Res (2008) 0.79
On the origin of the Aalpha chain heterogeneity of human fibrinogen. Biochim Biophys Acta (1977) 0.79
Urinary procoagulant and fibrinolytic activity in human glomerulonephritis. Relationship with renal function. Kidney Int (1991) 0.79
Generation of innovative anti-inflammatory and anti-arthritic glucocorticoid derivatives that release NO: the nitro-steroids. Dig Liver Dis (2003) 0.79
Influence of age on oxidative bursts (chemiluminescence) of polymorphonuclear neutrophil leukocytes. Gerontology (1998) 0.79
Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.79
Proceedings: The effect of endotoxins on generation of thrombin in the platelet atmosphere. Thromb Diath Haemorrh (1975) 0.79
Nicotine effects on polymorphonuclear cell apoptosis and lipopolysaccharide-induced monocyte functions. A possible role in periodontal disease? J Periodontal Res (2001) 0.79
Inhibitory effect of retinoids on the generation of procoagulant activity by blood mononuclear phagocytes. Thromb Haemost (1991) 0.79
Effects of nedocromil sodium on the oxidative burst of polymorphonuclear leukocytes: comparison with salbutamol. Drugs Exp Clin Res (1997) 0.78
Role of leucocyte procoagulant activity in endotoxin-induced DIC: evidence from comparative studies in rats and rabbits. Agents Actions (1981) 0.78
Procoagulant activity of human alveolar macrophages: different expression in patients with lung cancer. Int J Cancer (1986) 0.78
Permeability-related structures in developing and mature microvessels of the chicken optic tectum. Biol Struct Morphog (1992) 0.78
Rat blood leucocytes, unlike rabbit leucocytes, do not generate procoagulant activity on exposure to endotoxin. Br J Exp Pathol (1981) 0.78
Platelet-endotoxin interaction: a review. Boll Ist Sieroter Milan (1976) 0.78
Increased in vitro and in vivo generation of procoagulant activity (tissue factor) by mononuclear phagocytes after intralipid infusion in rabbits. Blood (1985) 0.78
Failure to warfarin to affect the tissue factor activity and the metastatic potential of murine fibrosarcoma cells. Eur J Cancer Clin Oncol (1985) 0.78
Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin? Haemostasis (1986) 0.78
Mechanisms of blood clotting activation in inflammation: the role of mononuclear phagocytes. Int J Tissue React (1985) 0.77
L: -carnitine fumarate and isovaleryl-L: -carnitine fumarate accelerate the recovery of bone volume/total volume ratio after experimetally induced osteoporosis in pregnant mice. Calcif Tissue Int (2008) 0.77
A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen). Arterioscler Thromb (1991) 0.77
[Expression of tissue factor and vascular endothelial growth factor in colorectal carcinoma]. Tumori (2003) 0.77
Inhibition of plasmin by antithrombin-heparin complex. II. During thrombolytic therapy in man. Br J Haematol (1978) 0.77
Reduced procoagulant activity of Lewis lung carcinoma cells from mice treated with warfarin. Eur J Cancer (1980) 0.77
Hemostatic variables in homozygous familial hypercholesterolemia. Effect of regular plasma cholesterol removal by low density lipoprotein apheresis. Arteriosclerosis (1990) 0.77
Leucocyte-dependent platelet activation: an alternative pathway for initiation of blood clotting in inflammation. Agents Actions (1981) 0.77
Fibrin down-regulates LPS- and PMA-induced tissue factor expression by blood mononuclear cells. Thromb Haemost (2000) 0.76
Increased macrophage procoagulant activity but normal endothelial thrombomodulin in rabbits fed an atherogenic diet. Haemostasis (1990) 0.76
Turnover of fibrinogen, plasminogen, and prothrombin during exercise in man. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.76
Angiogenesis and endothelium phenotype expression in embryonic adrenal gland and cerebellum grafted onto chorioallantoic membrane. Angiogenesis (1999) 0.76
Down-regulation of rat brain 5-HT uptake carriers after treatment with high doses of D-fenfluramine. Brain Res (1996) 0.76
In vitro effect of endotoxin from Shigella sonnei. phase I on human blood platelets and mononuclear leucocytes: comparison of "free endotoxin" with cell-extracted preparations. Microbiologica (1982) 0.76
Resistance to activated protein C (APC): influence of factor V levels. Thromb Haemost (1994) 0.76
Effect of acupressure on nausea and vomiting induced by chemotherapy in cancer patients. Minerva Med (2006) 0.76
The inhibition of plasmin by antithrombin-heparin complex. I. In human plasma in vitro. Br J Haematol (1978) 0.76
Pharmacodynamic effects on blood coagulation of a new low molecular weight heparin (alfa-LMWH) in healthy volunteers and gynecological surgery patients. Int Angiol (1989) 0.76
Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection. Thromb Res (2005) 0.76
Reduced fibrinolytic activity in glomeruli isolated from rabbits infused with tumor necrosis factor. Haemostasis (1994) 0.76
Pachydermoperiostosis: dermatological, neurological and radiological observations. Clin Rheumatol (1995) 0.75
Gastric emptying rate and hormonal response in type II diabetics. Diabetes Res (1991) 0.75
Occurrence of disseminated intravascular coagulation in rat BNML leukaemia despite lack of leucocyte procoagulant activity. Br J Exp Pathol (1983) 0.75
Vitamin E and vitamin C inhibit arachidonate-induced aggregation of human peripheral blood leukocytes in vitro. Agents Actions (1986) 0.75
The barrier systems in the choroidal plexuses of the chick embryo studied by means of horseradish peroxidase. J Submicrosc Cytol Pathol (1988) 0.75
Impaired production of mononuclear cell procoagulant activity in chronic lymphocytic leukaemia. J Clin Pathol (1983) 0.75
Monocytes, but not endothelial cells, downregulate the anticoagulant activity of activated protein C. Br J Haematol (2001) 0.75
Blood and tissue fibrinolytic profiles in patients with colorectal carcinoma. Int J Clin Lab Res (1995) 0.75
Process of differentiation of cerebellar Purkinje neurons in the chick embryo. Anat Embryol (Berl) (1986) 0.75
Tissue factor and vascular endothelial growth factor expression in colorectal cancer: relation with cancer recurrence. Colorectal Dis (2007) 0.75